Non-adherence to medication in rheumatic diseases is a major concern for patient's health, because incorrect use can result in less therapeutic benefits of treatment, including more disease activity and increased radiological damage. As a consequence, non-adherence may lead to more disability and lower health-related quality of life. Using Lowe's taxonomy1, the current state of evidence around medication adherence interventions will be presented. Examples of promising intervention strategies will be highlighted.
Lowe et al. (2011) Development of a taxonomy of interventions to organise the evidence on consumers' medicine use.
Disclosure of Interest None declared